[1]
« To Hold or Not to Hold? Periprocedural Management of Glucagon-like Peptide-1 Receptor‑based Agonists (GLP‑1ra) in Patients with Diabetes and Obesity », Can Diabetes Endocrinol Today, vol. 4, nᵒ 1, p. 26–34, mai 2026, doi: 10.58931/cdet.2026.4152.